Exploring factors affecting quality implementation of lymphatic filariasis mass drug administration in Bole and Central Gonja Districts in Northern Ghana
Open Access
- 17 August 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 14 (8) , e0007009
Abstract
Ghana has been implementing Mass Drug Administration (MDA) since the year 2001, and Lymphatic Filariasis transmission has been interrupted in 76 out of the 98 targeted districts. The remaining districts have a microfilaria prevalence above the 1% threshold needed for the interruption of transmission. This study assesses the level of lymphatic filariasis MDA coverage and explored factors affecting the quality of implementation of the MDA in the Bole and Central Gonja Districts of Northern Ghana. A concurrent mixed methods study design approach was used to provide both a quantitative and qualitative insight. A descriptive analysis was carried out, and the results are presented in tables and charts. The transcripts of the qualitative interviews were imported into Nvivo and framework methods of analysis were used. The results were summarized based on the themes and buttressed with narratives with key quotes presented within the texts. The overall MDA coverage in Central Gonja is 89.3% while that of Bole district is 82.9%. Refusal to ingest the drug and adverse drug reactions were higher in Bole district than the Central Gonja District. The persistent transmission of lymphatic filariasis in Bole District was characterized by poor community mobilization and sensitization, nonadherence to the directly observed treatment strategy, refusal to ingest the drug due to the fear of adverse drug reactions, inadequate knowledge and misconceptions about the disease. Reported mass drug administration coverage will not necessarily result into interruption of transmission of the disease without strict compliance to the directly observed treatment strategy, strong stakeholder engagement coupled with evidence-based context-specific multi-channel community education strategies with key educational messages on the cause of the disease and adverse drug reactions. While the clock for the elimination of lymphatic filariasis by the year 2020 and meeting of the Sustainable Development Goal 3 target 3.3 by 2030 is ticking, there is an urgent need for a concerted effort to improve the fidelity of the ongoing lymphatic filariasis MDA campaigns in the Bole District of Northern Ghana. After 18 years of implementing the global strategy to eliminate lymphatic filariasis in Ghana, the prevalence of the transmission of the disease is still above the threshold needed to interrupt transmission of the disease as a public health problem in some districts. This study showed that, the persistent transmission of the lymphatic filariasis in the Bole District is characterized with a refusal to ingest the drug; reported adverse drug reactions; poor knowledge and misconceptions of the disease, and poor adherence to the mass drug administration protocol. High reported mass drug administration coverage will not lead to interruption of transmission of lymphatic filariasis without strict adherence to the direct observe treatment strategy, strong stakeholder engagement coupled with evidence-based context-specific multi-channel community education strategies with key educational messages on adverse drug reactions and the cause of the disease.Keywords
Funding Information
- Special Program for Research and Training in Tropical Diseases, which is hosted at the World Health Organization and co-sponsored by UNICEF, UNDP, the World Bank and WHO (B40299)
This publication has 49 references indexed in Scilit:
- A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic FilariasisPLOS Neglected Tropical Diseases, 2013
- Epidemiological assessment of continuing transmission of lymphatic filariasis in SamoaPathogens and Global Health, 2011
- A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, HaitiPLOS Neglected Tropical Diseases, 2010
- Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008Tropical Medicine & International Health, 2010
- The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseasesParasites & Vectors, 2010
- Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, PhilippinesParasites & Vectors, 2008
- Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri LankaFilaria Journal, 2007
- Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri LankaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Participation in three consecutive mass drug administrations in Leogane, HaitiTropical Medicine & International Health, 2006
- Preventing confusion about side effects in a campaign to eliminate lymphatic filariasisTrends in Parasitology, 2005